MedPath

Friso MUM, the activity of a helath supplement during pregnancy and lactation.

Completed
Conditions
(Neurological development)
Registration Number
NL-OMON25238
Lead Sponsor
Friesland Foods, Leeuwarden. Department Friso Kindervoeding (Nutrition)
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

1. Apparently healthy pregnant women;

2. Para 0 or 1;

Exclusion Criteria

1. Hyperemesis Gravidarum

2. Vegetarian of Vegan;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eurological Development of the baby (Neurological Optimality Score and General Movements).
Secondary Outcome Measures
NameTimeMethod
1. Mood, cognitive functioning and sleeping rhythm of the mother; <br /><br>2. LCP status in red blood cells of mother (16th and 36th week) and child (12 weeks after birth), umbilical cord, breast milk (2 and 12 weeks after birth).
© Copyright 2025. All Rights Reserved by MedPath